Silexion Therapeutics Corp(SLXN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SLXN Silexion Therapeutics Corp

交易中 12-11 15:22:00 EST

3.01

-0.01

-0.33%

最高3.02	最低2.95	成交量3.88万
今开2.99	昨收3.02	日振幅2.32%
总市值941.12万	流通市值828.80万	总股本312.66万
成交额11.62万	换手率1.41%	流通股本275.35万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SLXN","market":"US","secType":"STK","nameCN":"Silexion Therapeutics Corp","latestPrice":3.01,"timestamp":1765484463534,"preClose":3.02,"halted":0,"volume":38784,"delay":0,"floatShares":2753490,"shares":3126642,"eps":-16.225569,"marketStatus":"交易中","change":-0.01,"latestTime":"12-11 15:22:00 EST","open":2.9928,"high":3.02,"low":2.95,"amount":116230.89308159999,"amplitude":0.023179,"askPrice":3.03,"askSize":100,"bidPrice":3,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-16.225569,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765486800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":3.02,"preHourTrading":{"tag":"盘前","latestPrice":2.99,"preClose":3.02,"latestTime":"09:24 EST","volume":1085,"amount":3235.3800535,"timestamp":1765463065389},"postHourTrading":{"tag":"盘后","latestPrice":3.04,"preClose":3.02,"latestTime":"19:59 EST","volume":916,"amount":2796.06,"timestamp":1765414757795},"volumeRatio":0.825607},"requestUrl":"/m/hq/s/SLXN/wiki","defaultTab":"wiki","newsList":[{"id":"1108369243","title":"Silexion Therapeutics获得德国卫生部门对其胰腺癌2/3期临床试验设计的积极反馈","url":"https://stock-news.laohu8.com/highlight/detail?id=1108369243","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108369243?lang=zh_cn&edition=full","pubTime":"2025-12-02 21:01","pubTimestamp":1764680504,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics获得德国卫生部门对其胰腺癌2/3期临床试验设计的积极反馈","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLXN","BK4139"],"gpt_icon":0},{"id":"1186776790","title":"Silexion Therapeutics 成功完成 Sil204 的毒理学研究，为胰腺癌的 2/3 阶段临床试验做好准备","url":"https://stock-news.laohu8.com/highlight/detail?id=1186776790","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186776790?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:16","pubTimestamp":1764080200,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics 成功完成了 Sil204 的毒理学研究，这是一种下一代 RNA 静默疗法，为即将进行的胰腺癌 2/3 阶段临床试验做好了准备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLXN"],"gpt_icon":0},{"id":"1183341465","title":"Silexion Therapeutics Corp公布积极的人体细胞系数据，证实Sil204的泛KRAS活性，抑制率高达99.7%，并首次在胃癌中显示疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1183341465","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183341465?lang=zh_cn&edition=full","pubTime":"2025-09-30 20:40","pubTimestamp":1759236051,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics Corp宣布公布积极的人体细胞系新数据，证实了其候选药物Sil204的泛KRAS活性。数据显示，该药物的抑制率高达99.7%，并首次在胃癌治疗中展现出积极效果。\n这项最新研究结果进一步验证了Sil204作为泛KRAS抑制剂的潜力，为该公司在肿瘤治疗领域的药物开发提供了重要支撑。特别值得关注的是，这是该药物首次在胃癌细胞中显示出治疗活性，为胃癌患者带来了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLXN"],"gpt_icon":0},{"id":"1172578975","title":"Silexion Therapeutics：最新数据显示Sil204成功抵达胰腺癌转移的所有主要部位","url":"https://stock-news.laohu8.com/highlight/detail?id=1172578975","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172578975?lang=zh_cn&edition=full","pubTime":"2025-09-11 19:06","pubTimestamp":1757588764,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics：最新数据显示Sil204成功抵达胰腺癌转移的所有主要部位","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLXN","BK4139"],"gpt_icon":0},{"id":"1118879000","title":"Silexion Therapeutics公布积极临床前数据，显示Sil204经系统给药后可到达胰腺癌主要转移部位并发挥活性","url":"https://stock-news.laohu8.com/highlight/detail?id=1118879000","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118879000?lang=zh_cn&edition=full","pubTime":"2025-09-11 19:02","pubTimestamp":1757588575,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics近日公布了令人鼓舞的临床前研究数据，证实其候选药物Sil204在系统给药后能够有效到达胰腺癌的主要转移部位并展现出治疗活性。这一研究结果为该公司在胰腺癌治疗领域的药物开发进展提供了重要支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLXN"],"gpt_icon":0},{"id":"1169989588","title":"Silexion Therapeutics宣布选定合同研究机构，为Sil204即将开展的2/3期临床试验提供支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1169989588","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169989588?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:25","pubTimestamp":1756992315,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics宣布选定合同研究机构，为Sil204即将开展的2/3期临床试验提供支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLXN"],"gpt_icon":0},{"id":"2511669489","title":"Silexion Therapeutics Corp盘中异动 股价大跌6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511669489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511669489?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:23","pubTimestamp":1739546591,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时23分，Silexion Therapeutics Corp股票出现波动，股价大幅下跌6.69%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Moleculin Biotech, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2430.41%、627.61%、476.65%，振幅较大的相关个股有Moleculin Biotech, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为66.93%、54.40%、43.67%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232311abcf1263&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232311abcf1263&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SLXN"],"gpt_icon":0},{"id":"2511529975","title":"Silexion Therapeutics Corp盘中异动 早盘急速下跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511529975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511529975?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:47","pubTimestamp":1739458051,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时47分，Silexion Therapeutics Corp股票出现异动，股价快速下挫5.19%。截至发稿，该股报1.28美元/股，成交量11.07万股，换手率2.77%，振幅3.70%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体涨幅为0.03%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224731a244af6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224731a244af6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SLXN"],"gpt_icon":0},{"id":"2510289338","title":"Silexion Therapeutics Corp盘中异动 早盘急速拉升6.87%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510289338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510289338?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284262,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Silexion Therapeutics Corp股票出现异动，股价快速上涨6.87%。截至发稿，该股报1.40美元/股，成交量84.0262万股，换手率21.03%，振幅0.00%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体跌幅为0.92%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223102a241fac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223102a241fac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SLXN","BK4139"],"gpt_icon":0},{"id":"2510864637","title":"Silexion Therapeutics Corp盘中异动 早盘股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510864637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510864637?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:55","pubTimestamp":1739202912,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时55分，Silexion Therapeutics Corp股票出现异动，股价快速上涨5.56%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2678.06%、1538.49%、1022.06%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为87.80%、76.30%、66.09%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210235512abc9b70b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210235512abc9b70b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SLXN","BK4139"],"gpt_icon":0},{"id":"2509974474","title":"Silexion Therapeutics Corp盘中异动 股价大跌6.25%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509974474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509974474?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:37","pubTimestamp":1738939048,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时37分，Silexion Therapeutics Corp股票出现波动，股价快速下挫6.25%。截至发稿，该股报1.35美元/股，成交量21.6598万股，换手率5.42%，振幅4.86%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体涨幅为0.02%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223728987daea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223728987daea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SLXN"],"gpt_icon":0},{"id":"2509282483","title":"Silexion Therapeutics Corp盘中异动涨6.00% 振幅达10.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509282483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509282483?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:36","pubTimestamp":1738766204,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时36分，Silexion Therapeutics Corp股票出现波动，股价快速上涨6.00%。截至发稿，该股报1.33美元/股，成交量43.6581万股，换手率10.93%，振幅10.00%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体涨幅为0.78%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223644987b7cbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223644987b7cbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SLXN","BK4139"],"gpt_icon":1},{"id":"2508845726","title":"Silexion Therapeutics Corp盘中异动 急速跳水5.10%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508845726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508845726?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:31","pubTimestamp":1738679480,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时31分，Silexion Therapeutics Corp股票出现波动，股价快速下跌5.10%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Azitra Inc、Evaxion Biotech As、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为836.24%、675.65%、185.77%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Omega Therapeutics, Inc.、Azitra Inc，振幅分别为19.74%、18.97%、14.22%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223121a239289f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223121a239289f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SLXN"],"gpt_icon":1},{"id":"2508141854","title":"Silexion Therapeutics Corp盘中异动 大幅跳水14.21%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508141854?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:31","pubTimestamp":1738593074,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时31分，Silexion Therapeutics Corp股票出现波动，股价急速下挫14.21%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为312.19%、197.59%、126.11%，振幅较大的相关个股有Jupiter Neurosciences, Inc.、Lipocine Inc.、Biocardia, Inc.，振幅分别为4.85%、4.40%、4.05%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223114abc1065f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223114abc1065f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLXN","LENZ","BK4139"],"gpt_icon":1},{"id":"2507621185","title":"Silexion Therapeutics Corp盘中异动 股价大跌30.89%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507621185?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:31","pubTimestamp":1738247489,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时31分，Silexion Therapeutics Corp股票出现波动，股价快速跳水30.89%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为579.75%、116.91%、92.41%，振幅较大的相关个股有Tectonic Therapeutic, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Kazia Therapeutics Limited，振幅分别为16.36%、15.36%、10.14%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223129abbd4c10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223129abbd4c10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLXN","LENZ"],"gpt_icon":1},{"id":"2506034313","title":"Silexion Therapeutics Corp盘中异动 早盘快速下跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506034313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506034313?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:39","pubTimestamp":1737988746,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时39分，Silexion Therapeutics Corp股票出现异动，股价快速下挫5.35%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体涨幅为1.00%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Moolec Science Sa C/Wts 涨幅较大，Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.、Evaxion Biotech As较为活跃，换手率分别为55.83%、44.50%、41.92%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Immatics N V C/Wts 01/07/2025 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为65.16%、53.75%、41.06%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223906abba6170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223906abba6170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLXN","BK4139","LENZ"],"gpt_icon":0},{"id":"2506895000","title":"Silexion Therapeutics Corp盘中异动 股价大涨5.50%报0.694美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506895000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506895000?lang=zh_cn&edition=full","pubTime":"2025-01-25 01:26","pubTimestamp":1737739617,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日01时26分，Silexion Therapeutics Corp股票出现异动，股价大幅拉升5.50%。截至发稿，该股报0.694美元/股，成交量46.8167万股，换手率11.72%，振幅8.36%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体涨幅为0.43%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125012657a22e7f63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125012657a22e7f63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLXN","LENZ","BK4139"],"gpt_icon":0},{"id":"2505540014","title":"Silexion Therapeutics Corp盘中异动 急速下挫5.08%报0.704美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505540014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505540014?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:36","pubTimestamp":1737642965,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时36分，Silexion Therapeutics Corp股票出现异动，股价大幅下挫5.08%。截至发稿，该股报0.704美元/股，成交量14.2539万股，换手率3.57%，振幅7.28%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体涨幅为0.03%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223605a22d0a58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223605a22d0a58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SLXN","BK4139"],"gpt_icon":0},{"id":"2505441271","title":"Silexion Therapeutics Corp盘中异动 早盘股价大跌6.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505441271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505441271?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:36","pubTimestamp":1737470161,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时36分，Silexion Therapeutics Corp股票出现异动，股价大幅下挫6.81%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Dogwood Therapeutics, Inc.、Replimune Group, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Dermata Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为563.53%、162.28%、44.11%，振幅较大的相关个股有Allakos Inc.、Dominari Holdings Inc.、Equillium, Inc.，振幅分别为111.05%、108.29%、107.00%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223601a22a5812&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223601a22a5812&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLXN","LENZ"],"gpt_icon":0},{"id":"2504161764","title":"Silexion Therapeutics Corp盘中异动 早盘大幅跳水5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504161764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504161764?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:33","pubTimestamp":1737124429,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时33分，Silexion Therapeutics Corp股票出现异动，股价快速下跌5.85%。Silexion Therapeutics Corp股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Channel Therapeutics Corporation涨幅较大，Aditxt, Inc.、Aeon Biopharma, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为95.59%、14.47%、6.89%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Surrozen Inc C/Wts 01/08/2031 、Allakos Inc.，振幅分别为43.37%、25.64%、10.99%。Silexion Therapeutics Corp公司简介：Silexion Therapeutics Corp是一家处于发展阶段的公司，致力于开发胰腺癌治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223349986a1585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223349986a1585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SLXN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.silexion.com","stockEarnings":[{"period":"1week","weight":0.0982},{"period":"1month","weight":0.0863},{"period":"3month","weight":-0.3874},{"period":"6month","weight":-0.7698},{"period":"1year","weight":-0.926},{"period":"ytd","weight":-0.8998}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Silexion Therapeutics Corp是一家开曼群岛豁免公司。Silexion Therapeutics Ltd.是Biomotion Sciences的子公司。Silexion Therapeutics Ltd.是一家临床阶段、专注于肿瘤学的生物技术公司，致力于发现和开发KRAS驱动的癌症的专有疗法。Silexion的主要候选产品SIL-204B由局部给药的小干扰RNA或siRNA组成，采用缓释制剂，作为局部晚期胰腺癌患者的一线治疗，与标准护理化疗相结合。SIL-204B是继Silexion的第一代siRNA候选产品SIG12D-LODER（也称为Loder）的1期和2期临床试验之后的第二代siRNA候选产品。尽管未确定最大耐受剂量，但1期临床试验同时达到了主要和次要终点。在2期临床试验中，虽然没有达到所有患者的主要终点，但结果显示KRAS G12D/V突变患者的治疗组之间存在差异趋势，Loder组的总体生存期优势为9.3个月。关于2期临床试验中的次要安全性终点，达到了终点。对于次要疗效终点，未观察到统计学上的显著差异，也没有足够的数据进行评估。由于1期和2期试验的规模较小，它们没有提供统计学意义。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.0087},{"month":2,"riseRate":0.75,"avgChangeRate":-0.104682},{"month":3,"riseRate":1,"avgChangeRate":0.013692},{"month":4,"riseRate":0.75,"avgChangeRate":-0.019534},{"month":5,"riseRate":0.4,"avgChangeRate":0.010327},{"month":6,"riseRate":0.4,"avgChangeRate":-0.035519},{"month":7,"riseRate":1,"avgChangeRate":0.055675},{"month":8,"riseRate":0.4,"avgChangeRate":-0.277749},{"month":9,"riseRate":0.6,"avgChangeRate":-0.230878},{"month":10,"riseRate":0.4,"avgChangeRate":-0.091257},{"month":11,"riseRate":0.4,"avgChangeRate":-0.018649},{"month":12,"riseRate":0.4,"avgChangeRate":-0.042311}],"exchange":"NASDAQ","name":"Silexion Therapeutics Corp","nameEN":"Silexion Therapeutics Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Silexion Therapeutics Corp(SLXN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Silexion Therapeutics Corp(SLXN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Silexion Therapeutics Corp,SLXN,Silexion Therapeutics Corp股票,Silexion Therapeutics Corp股票老虎,Silexion Therapeutics Corp股票老虎国际,Silexion Therapeutics Corp行情,Silexion Therapeutics Corp股票行情,Silexion Therapeutics Corp股价,Silexion Therapeutics Corp股市,Silexion Therapeutics Corp股票价格,Silexion Therapeutics Corp股票交易,Silexion Therapeutics Corp股票购买,Silexion Therapeutics Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Silexion Therapeutics Corp(SLXN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Silexion Therapeutics Corp(SLXN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}